| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.15 | 0.4 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.4 |